Elcelyx Therapeutics Secures $4,000,000 Series B Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=bf320a24-5854-4f9e-94dc-97d0bf2858c8&Preview=1 -
Date
8/13/2012 -
Company Name
Elcelyx Therapeutics -
Mailing Address
11995 El Camino Real San Diego, CA 92130 -
Company Description
Elcelyx Therapeutics of San Diego is a stealth mode diabetes related biotechnology company. -
Website
http://www.elcelyx.com -
Transaction Type
Venture Equity -
Transaction Amount
$4,000,000 -
Transaction Round
Series B -
Proceeds Purposes
The new financing will support clinical trials for proprietary product candidates Lovidia(TM) for use in nutritional supplement, food and beverage applications, and NewMet(TM) for patients with Type 2 diabetes. -
M&A Terms
-
Venture Investor
Morgenthaler Ventures -
Venture Investor
Kleiner Perkins Caufield & Byers -
Venture Investor
Technology Partners
